BIOSGN.ST
Price:
$50.2
Market Cap:
$117.88M
Biosergen AB, a biopharmaceutical company, engages in the development of antifungal products. It is developing BSG005, an antifungal drug candidate for the treatment of life threatening invasive fungal diseases. The company was founded in 2004 and is headquartered in Solna, Sweden.
Industry
Biotechnology
IPO Date
2021-06-24
Stock Exchange
STO
Ticker
BIOSGN.ST
According to Biosergen AB’s latest financial reports and current stock price. The company's current Current Ratio is 7.09. This represents a change of -15.29% compared to the average of 8.37 of the last 4 quarters.
The mean historical Current Ratio of Biosergen AB over the last ten years is 3.80. The current 7.09 Current Ratio has changed 18.54% with respect to the historical average. Over the past ten years (40 quarters), BIOSGN.ST's Current Ratio was at its highest in in the December 2024 quarter at 14.25. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
3.80
Median
2.24
Minimum
0.31
Maximum
14.25
Discovering the peaks and valleys of Biosergen AB Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 944.23%
Maximum Annual Current Ratio = 14.25
Minimum Annual Increase = -53.91%
Minimum Annual Current Ratio = 0.31
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 14.25 | 906.20% |
| 2023 | 1.42 | -53.91% |
| 2022 | 3.07 | -3.57% |
| 2021 | 3.19 | 944.23% |
| 2020 | 0.31 | -48.05% |
The current Current Ratio of Biosergen AB (BIOSGN.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.25
5-year avg
4.45
10-year avg
3.80
Biosergen AB’s Current Ratio is greater than Nanologica AB (publ) (2.50), greater than Biovica International AB (publ) (0.86), greater than Active Biotech AB (publ) (1.17), less than NextCell Pharma AB (10.02), greater than Arcoma AB (3.14), greater than Pila Pharma AB (publ) (0.95), greater than Scandinavian ChemoTech AB (publ) (1.17), greater than Xbrane Biopharma AB (publ) (3.47), greater than Sprint Bioscience AB (publ) (1.13), greater than SciBase Holding AB (publ) (2.49),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.50 | $75.11M | |
| 0.86 | $114.88M | |
| 1.17 | $78.73M | |
| 10.02 | $81.87M | |
| 3.14 | $103.88M | |
| 0.95 | $98.48M | |
| 1.17 | $86.97M | |
| 3.47 | $115.41M | |
| 1.13 | $160.91M | |
| 2.49 | $139.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biosergen AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biosergen AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Biosergen AB's Current Ratio?
How is the Current Ratio calculated for Biosergen AB (BIOSGN.ST)?
What is the highest Current Ratio for Biosergen AB (BIOSGN.ST)?
What is the 3-year average Current Ratio for Biosergen AB (BIOSGN.ST)?
What is the 5-year average Current Ratio for Biosergen AB (BIOSGN.ST)?
How does the current Current Ratio for Biosergen AB (BIOSGN.ST) compare to its historical average?